Basel, 05 January 2021
Invitation to Roche's Full Year Results 2020 Presentation Invitation to Roche's Full Year Results 2020 Presentation
Roche will publish its Full Year Results for 2020 prior to the opening of the Swiss Stock
Exchange on Thursday, 4 February 2021.
07:00 CET / 06:00 GMT / 01:00 AM EST / 10:00 PM PST (evening before)
Release will be e-mailed and posted on the Roche IR website click here
Presentation slides will be posted on the Roche IR website click here
14:00 - 16:00 CET / 13:00 - 15:00 GMT
08:00 - 10:00 AM EST / 05:00 - 07:00 AM PST
The webinar will start with presentations by senior management, followed by a Q&A session.
Presenters:
- Severin Schwan, CEO Roche Group
- Bill Anderson, CEO Roche Pharmaceuticals
- Thomas Schinecker, CEO Roche Diagnostics
- Alan Hippe, Chief Financial and IT Officer
We would like to invite all interested parties to participate in the webinar and to pre-register for the event here.*
Should you be unable to register for the webinar due to your company IT policy, please send an email to investor.relations@roche.com.
A replay of the webcast will be available via ir.roche.com
*privacy notice
Best regards,
Karl Mahler
Head of Investor Relations and Roche Group Planning
Roche Investor Relations | |
Dr. Karl Mahler Phone: +41 61 68-78503 e-mail: karl.mahler@roche.com |
Dr. Sabine Borngräber |
Dr. Bruno Eschli |
Dr. Birgit Masjost Phone: +41 61 68-84814 e-mail: birgit.masjost@roche.com |
Dr. Gerard Tobin Phone: +41 61 68-72942 e-mail: gerard.tobin@roche.com |
Jon Kaspar Bayard Phone: +41 61 68-83894 e-mail: jon_kaspar.bayard@roche.com |
Investor Relations North America | |
Loren Kalm Phone: +1 650 225 3217 e-mail: kalm.loren@gene.com |
Dr. Lisa Tuomi Phone: +1 650 467 8737 e-mail: tuomi.lisa@gene.com |
Attachments
- Original document
- Permalink
Disclaimer
Roche Holding AG published this content on 05 January 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 05 January 2021 09:03:02 UTC